Sartorius Stedim Biotech (DIM) — key financial figures for fiscal year 2025 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

€3.0B

Net Income/Loss (FY2025)

€266.0M

Total Assets (FY2025)

€8.0B

Total Equity (FY2025)

€4.1B

Cash Flows from Operating Activities (FY2025)

€692.2M

Source: Sartorius Stedim Biotech annual_report filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.